The rates of tumor growth inhibition in the xenograft of the GLUT-1 AS-ODN group, wortmannin group, wortmannin plus GLUT-1 AS-ODN group, 10-Gy group, wortmannin plus 10-Gy group, and wortmannin plus GLUT-1 AS-ODN plus 10-Gy group were 37.3%, 53.4%, 43.5%, 7.0%, 68.1%, and 70.0%, respectively. This evidence concerns the gene SLC2A1 and neoplasm.